Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000230290 | SCV000290283 | benign | Adams-Oliver syndrome 5 | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000430521 | SCV000525687 | benign | not specified | 2016-11-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000769595 | SCV000738345 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-04-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Human Genetics, |
RCV000660171 | SCV000782165 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000769595 | SCV000900992 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2017-01-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000230290 | SCV002554326 | benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270049 | SCV002554328 | benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002500804 | SCV002805005 | benign | Aortic valve disease 1; Adams-Oliver syndrome 5 | 2021-07-02 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001723823 | SCV004010899 | likely benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | NOTCH1: BP4, BP7, BS2 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000430521 | SCV004029515 | benign | not specified | 2023-07-21 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000430521 | SCV001808910 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001723823 | SCV001954630 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001723823 | SCV001968986 | likely benign | not provided | no assertion criteria provided | clinical testing |